Literature DB >> 12706288

NF-kappaB and TNF-alpha stimulate androgen receptor expression in Sertoli cells.

Frank J Delfino1, Jared N Boustead, Charity Fix, William H Walker.   

Abstract

Germ cell development within the mammalian testis requires testosterone stimulation of somatic Sertoli cells via interaction with intracellular androgen receptors (AR). AR expression levels undergo marked changes during spermatogenesis suggesting that the modulation of AR expression is an important mechanism to regulate Sertoli cell responsiveness to testosterone. An analysis of the AR gene promoter revealed three kappaB enhancer elements that interacted with Sertoli cell p50 and RelA NF-kappaB proteins, and the overexpression of these NF-kappaB subunits in Sertoli cells stimulated AR promoter activity. Moreover, TNF-alpha, a secretory product of round spermatids, stimulated NF-kappaB binding to the AR promoter, induced AR promoter activity, and increased endogenous AR expression in primary cultures of Sertoli cells. Given the requirement of testosterone for spermatogenesis and the importance of AR in mediating Sertoli cell responsiveness to testosterone, the stimulation of AR expression by NF-kappaB and TNF-alpha may represent an important regulatory mechanism required to maintain efficient spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706288     DOI: 10.1016/s0303-7207(03)00005-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  25 in total

Review 1.  A local autocrine axis in the testes that regulates spermatogenesis.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Nat Rev Endocrinol       Date:  2010-07       Impact factor: 43.330

2.  Honokiol inhibits androgen receptor activity in prostate cancer cells.

Authors:  Eun-Ryeong Hahm; A Isabella Karlsson; Michael Y Bonner; Jack L Arbiser; Shivendra V Singh
Journal:  Prostate       Date:  2013-12-11       Impact factor: 4.104

Review 3.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

Review 4.  NF-κB signaling in prostate cancer: a promising therapeutic target?

Authors:  Garima Jain; Marcus V Cronauer; Mark Schrader; Peter Möller; Ralf B Marienfeld
Journal:  World J Urol       Date:  2011-11-16       Impact factor: 4.226

5.  Network analysis of human glaucomatous optic nerve head astrocytes.

Authors:  Tatiana Nikolskaya; Yuri Nikolsky; Tatiana Serebryiskaya; Svetlana Zvereva; Eugene Sviridov; Zoltan Dezso; Eugene Rahkmatulin; Richard J Brennan; Nick Yankovsky; Sanjoy K Bhattacharya; Olga Agapova; M Rosario Hernandez; Valery I Shestopalov
Journal:  BMC Med Genomics       Date:  2009-05-09       Impact factor: 3.063

6.  Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells.

Authors:  Silvia D Stan; Shivendra V Singh
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

Review 7.  Cytokines and junction restructuring events during spermatogenesis in the testis: an emerging concept of regulation.

Authors:  Michelle W M Li; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  Cytokine Growth Factor Rev       Date:  2009-08-03       Impact factor: 7.638

Review 8.  Polarity proteins and cell-cell interactions in the testis.

Authors:  Elissa W P Wong; C Yan Cheng
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 9.  Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?

Authors:  Yiwei Li; Dejuan Kong; Aamir Ahmad; Bin Bao; Fazlul H Sarkar
Journal:  Antioxid Redox Signal       Date:  2013-03-14       Impact factor: 8.401

Review 10.  Regulation of spermatogenesis in the microenvironment of the seminiferous epithelium: new insights and advances.

Authors:  C Yan Cheng; Elissa W P Wong; Helen H N Yan; Dolores D Mruk
Journal:  Mol Cell Endocrinol       Date:  2009-08-12       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.